Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Intelligent Bio Solutions (INBS) Non-Current Receivables (2021 - 2022)

Intelligent Bio Solutions has reported Non-Current Receivables over the past 2 years, most recently at $1.1 million for Q4 2022.

  • For Q4 2022, Non-Current Receivables fell 6.46% year-over-year to $1.1 million; the TTM value through Dec 2022 reached $1.1 million, down 6.46%, while the annual FY2022 figure was $1.1 million, 65.29% down from the prior year.
  • Non-Current Receivables for Q4 2022 was $1.1 million at Intelligent Bio Solutions, up from $1.0 million in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $3.1 million in Q2 2021 and troughed at $1.0 million in Q3 2022.